Carmila: Asset Sale in France for €35 Million
03 Agosto 2023 - 12:45PM
Business Wire
Regulatory News:
Carmila (Paris:CARM) announces the signing of an agreement with
Etixia (the property company of Kiabi) for the sale of Bay 1 in
Torcy, in the Ile-de-France region. This asset, acquired in 2014
and 100% occupied, consists of 25 units, including many innovative
restaurant concepts and several mid-sized stores.
The sale price of €35 million including transfer taxes is in
line with the appraisal value. The transaction is expected to close
in the second half of 2023.
This agreed sale follows the disposal of an asset in Tarnos,
France, in the second quarter of 2023, for €8 million including
transfer taxes, in connection with Carmila’s new target, announced
in February 2023, to sell a further €100 million of assets by end
2024.
INVESTOR AGENDA 20 October 2023 (after market
close): Third-quarter 2023 financial information
ABOUT CARMILA
As the third-largest listed owner of commercial property in
continental Europe, Carmila was founded by Carrefour and large
institutional investors in order to transform and enhance the value
of shopping centres adjoining Carrefour hypermarkets in France,
Spain and Italy. At 30 June 2023, its portfolio was valued at €6.0
billion, comprising 202 shopping centres, all leaders in their
catchment areas.
Carmila is listed on Euronext-Paris Compartment A under the
symbol CARM. It benefits from the tax regime for French real estate
investment trusts (“SIIC”).
Carmila has been a member of the SBF 120 since 20 June 2022.
Important notice
Some of the statements contained in this document are not
historical facts but rather statements of future expectations,
estimates and other forward-looking statements based on
management’s beliefs. These statements reflect such views and
assumptions prevailing as of the date of the statements and involve
known and unknown risks and uncertainties that could cause future
results, performance or events to differ materially from those
expressed or implied in such statements. Please refer to the most
recent Universal Registration Document filed in French by Carmila
with the Autorité des marchés financiers for additional information
in relation to such factors, risks and uncertainties. Carmila has
no intention and is under no obligation to update or review the
forward-looking statements referred to above. Consequently, Carmila
accepts no liability for any consequences arising from the use of
any of the above statements.
This press release is available in the
“Financial Press Releases” section of Carmila’s Finance webpage:
https://www.carmila.com/en/finance/financial-press-releases
Visit our website at
https://www.carmila.com/en/
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230803892322/en/
INVESTOR AND ANALYST CONTACT Jonathan Kirk – Head of Investor
Relations jonathan_kirk@carmila.com +33 6 31 71 83 98
PRESS CONTACT Elodie Arcayna – Corporate Communications Director
elodie_arcayna@carmila.com +33 7 86 54 40 10
Carisma Therapeutics (NASDAQ:CARM)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Carisma Therapeutics (NASDAQ:CARM)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024